AHFS Drug Informationauthority of the Board of Directors of the American Society of Hospital Pharmacists, 1990 - Drugs |
Other editions - View all
Common terms and phrases
acid activity acute addition administration adults adverse effects agents AIDS AIDS-related Kaposi's sarcoma amphotericin and/or antibodies antineoplastic antiviral appear approximately associated bone marrow carcinoma caused Cautions cell chronic clinical combined compared complete concentrations containing currently daily decreased determine discontinuance disease dosages dose drug enhance evidence evidence suggests factor fluconazole function further given half-life hepatitis human immune increased indicate infection inhibition initial interferon alfa therapy interferon alfa-2a intralesional ketorolac tromethamine least lesions less leukemia limited manufacturer million units months name not established needed normal observed occur oral patients receiving plasma possible potential preparations produced prolonged protein range reaction receiving interferon alfa recommended reduction relatively renal reported respectively response risk serum severe single solution studies substantial suggests syndrome systemic toxicity trade name treatment tumor usually vaccine viral virus vitro warts weeks